Prescription drug · BLA
Infasurf (Calfactant) NDC 61938-456
Calfactant 35.7 mg/mL · Suspension · Endotracheal · ONY Biotech Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 61938-456-03 | 61938045603 | 1 VIAL, GLASS in 1 CARTON (61938-456-03) / 3 mL in 1 VIAL, GLASSMarketed from Dec 12, 2002 | |
| 61938-456-06 | 61938045606 | 1 VIAL, GLASS in 1 CARTON (61938-456-06) / 6 mL in 1 VIAL, GLASSMarketed from Oct 18, 1999 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Infasurf
- Generic name (nonproprietary)
- calfactant
- Active ingredients
- Calfactant — 35.7 mg/mL
- Dosage form
- Suspension
- Route
- Endotracheal
- Labeler
- ONY Biotech Inc.NDC labeler code 61938
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 020521
- Marketing start
- Listing expires
- Other FDA classes
- Alveolar Surface Tension Reduction (Physiologic effect)Surfactant Activity (Mechanism)
- Identifiers
- Product ID 61938-456_49ede145-f336-f2b5-e063-6294a90aefceSPL ID 49ede145-f336-f2b5-e063-6294a90aefceSPL set ID 315c128a-272d-4c57-bfbe-1a8b3402af08RxCUI 259611, 994039UNII Q4K217VGA9UPC 0361938456063, 0361938456032
- Pharmacologic class
- Surfactant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N461938045603followed by a unit qualifier and the quantityPackage 61938-0456-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INFASURF is indicated: to reduce the risk of respiratory distress syndrome (RDS) in preterm neonates <29 weeks of gestational age at risk for RDS. for the rescue treatment of RDS in preterm neonates ≤72 hours of age with RDS who require endotracheal intubation. INFASURF ® is a surfactant indicated: to reduce the risk of respiratory distress syndrome (RDS) in preterm neonates < 29 weeks gestational age at risk for RDS. (1) for the rescue treatment of preterm neonates ≤72 hours of age with RDS who require endotracheal intubation. (1)
Excerpt only. Read the full label for complete information.
About NDC 61938-456
- What is NDC 61938-456?
- 61938-456 is the product NDC for Infasurf (calfactant), Calfactant 35.7 mg/mL suspension, listed with the FDA by ONY Biotech Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Infasurf (Calfactant).
- What is the active ingredient?
- Calfactant.
- Who is the labeler?
- ONY Biotech Inc., NDC labeler code 61938. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Infasurf?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.